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Purpose: High Dose Rate (HDR) Brachytherapy is a radiation treatment technique capable of delivering large dose rates to the tumour. Radiation is delivered using remote afterloaders to drive highly active sources (commonly 192 Ir with an air KERMA strength range between 20000 to 40000 U, where 1U = 1 μGy m 2 /h in air) through applicators directly into the patient's prescribed region of 15 treatment. Due to the obvious ramifications of incorrect treatment while using such an active source, it is essential that there are methods for quality assurance (QA) that can directly and accurately verify the treatment plan and the functionality of the remote afterloader. This paper describes the feasibility study of a QA system for HDR brachytherapy using a phantom based two-dimensional 11x11 epitaxial diode array, named "Magic Phantom". 20
Methods:
The HDR brachytherapy treatment plan is translated to the phantom with two rows of 10 (20 in total) HDR source flexible catheters, arranged above and below the diode array "Magic Plate" (MP). Four dimensional source tracking in each catheter is based upon a developed fast iterative algorithm, utilising the response of the diodes in close proximity to the 192 Ir source, sampled at 100 ms intervals by a fast data acquisition (DAQ) system. Using a 192 Ir source in a solid water phantom, 25 the angular response of the developed epitaxial diodes utilised in the MP and also the variation of the MP response as a function of the source-to-detector distance (SDD) were investigated. These response data are then used by an iterative algorithm for source dwelling position determination. A measurement of the average transit speed between dwell positions was performed using the diodes and a fast DAQ. 30
Results:
The angular response of the epitaxial diode showed a variation of 15% within 360°, with two flat regions above and below the detector face with less than 5% variation. For SDD distances of between 5 and 30 mm the relative response of the epitaxial diodes used in the MP is in good agreement (within 8%) with radial dose function measurements found within the TG-43 protocol, with SDD of up to 70 mm showing a 40% over response. A method for four dimensional localisation 35 of the HDR source was developed, allowing the source dwell position to be derived within 0.50 mm of the expected position. An estimation of the average transit speed for varying step sizes was determined and was found to increase from (12.8 ± 0.3) cm/s up to (38.6 ± 0.4) cm/s for a step size of 2.5 mm and 50 mm, respectively.
Conclusions:
Our characterisation of the designed QA "Magic Phantom" with MP in realistic HDR 40 photon fields demonstrates the promising performance for real-time source position tracking in four dimensions and measurements of transit times. Further development of this system will allow a full suite for QA in HDR brachytherapy and analysis, and for future in-vivo tracking.
I. Introduction 45
High Dose Rate (HDR) brachytherapy has shown to be beneficial due to its ability to provide a highly localised dose in short treatment times. The advantages and disadvantages of this technique have been well documented within TG-59 report 1 . As brachytherapy involves high dose rates (air KERMA strength range between 20000 to 40000 U), minimal fractionations and short treatment times, it is essential that treatments are delivered with high accuracy, as errors will result in severe 50 complications 2,3 .
While contemporary radiotherapy is very accurate, errors have happened. More than 500 HDR accidents (including one death 2 ) have been reported along the entire chain of procedures from source packing to delivery of dose 3 . Although most errors in brachytherapy have been the result of human errors, rather than failure of the treatment delivery system and treatment planning, the fast verification 55 of the remote afterloading units and generated treatment plans are important in a "good" quality assurance program. The American Association of Physicists in Medicine ratified that to guarantee a good quality assurance program, the medical physicist should be able to accurately measure the source position, timing, transit velocity and, ideally, absorbed dose distribution 4 .
An ideal system for treatment verification should be able to provide the 3D identification of the dwell 60 positions, measure the dwell and transit times, and compare in real-time these parameters with the treatment planning. In the literature there are several studies that investigate different HDR brachytherapy Quality Assurance (QA) approaches. The main goal of the majority of these studies, described below, was to develop a method of localising the source dwell positions and measure timing patterns. 65 A pinhole imaging system, coupled with an x-ray fluoroscope and radiographic screen-film was developed by Duan et al 5 . The system has two pinholes placed away from the patient and is used to reconstruct the source dwell positions in three dimensions using a triangulation reconstruction algorithm. The source was localised within 1 mm and allowed for recording of a HDR treatment by the fluoroscopy machine on to a standard VCR video-tape for post-treatment verification. This 70 method, while able to reconstruct the source position in post-processing of film, relied on the user to notice any significant deviations in position via the fluoroscope screen during actual treatment.
Nakano et al
6 proposed the use of diamond detectors for HDR source localisation. The detectors were characterised for their use in HDR, and, using a suggested triangulation method with a minimum of 3 detectors, the source position could be calculated in three dimensions. The intended method would 75 able to localise the source with an accuracy of 2 mm, according to the authors, within a source to detector distance of 1 to 12 cm, based on the dose to SDD fit used.
A method for using a mobile C-arm fluoroscopy machine to image the check cable at dwell positions prior to treatment was investigated by Liu et al 7 . Verifying by visual inspection, the authors remarked that the method is useful for observing gross errors, larger than 1 cm, in dwell positions. 80
The use of a single flat panel detector for tracking the brachytherapy source has been described by This study explores the characterisation of the MP and "magic phantom" for pre-treatment QA system in terms of real time identification of dwell time and source positioning and verification of the transit timing for different distances between dwelling positions. The system is based on a novel adapted for HDR QA 2D diode array, MP, developed at the Centre for Medical Radiation Physics (CMRP), University of Wollongong, which was originally designed as a dosimeter for IMRT/VMAT quality 145 assurance 16 .
II. Materials
Several studies have been carried out examining the use of silicon diodes for dosimetry in conventional and intensity-modulated external beam radiotherapy 17, 18, 19, 20, 21 . All these studies agree on the selection of p-type silicon detectors as the best candidate for dosimetry of high energy photons 150 for their high radiation hardness and reproducibility of the response. The MP detector was originally designed for IMRT radiation therapy quality assurance. It comprises of an 11x11 array of epitaxial silicon p-type diodes embedded into a 0.5 mm thick Kapton carrier (Figure 1 ). Its specialised packaging, using "Drop-in" technology, has been designed to minimise perturbation of the radiation field, avoid dose enhancement due to high Z materials and to maximise the flexibility of the detector 155 to be adaptable to curved shape surfaces such as the human body. MP is 99.8% transparent in a 6 MV photon field when used in fluence mode 16 . The TERA06 is used in conjunction with a Field Programmable Gate Array (FPGA) module. The digital readout and back-end system was designed and developed by the CMRP, and is equipped with a custom designed C++ multi-platform user interface, so named "Rad-X DoseView". It is capable of reading out each detector in the MP array with zero dead time over a variable acquisition time 170
(between 100μs -100 ms) with real time visualisation and data analysis.
For pre-treatment verification, the MP based phantom system will be able to assess a complete HDR treatment, by verifying the dwell positions and timings, the transit between dwell positions, and the integral dose delivered to the MP diodes for the verified treatment. It allows for comparison with a plan imported from the treatment planning system that is translated to the "magic phantom" and 175 would be capable of real time verification providing identification of error on a particular step of treatment.
The MP is sandwiched in a solid water phantom, "magic phantom", with two insertable rows of 10 catheter holes, up to 20 in total, to suit the needs of the HDR afterloader and prescribed treatment plan as seen in Figure 2 . The MP is positioned between the rows of holes and is used to reconstruct in real 180 time the position of the source within the phantom, moving according to the prescribed treatment plan. To measure the azimuth angular response the diode was placed within a rotatable cylindrical phantom that was encased in a cubic phantom of 30x30x30 cm 3 solid water, to ensure full body scattering conditions. A HDR prostate brachytherapy catheter was placed at 20 mm SDD, as seen in Figure 4 .
Initial position (θ = 0°) was taken as when the orientation of the detector's sensitive volume was 210 'face-up' relative to the source.
Using a 28000 U 192 Ir source, the MicroSelectron HDR brachytherapy afterloader was programmed to position the source to a distance of 1240 mm (final dwell position at the end of the catheter) for 45 seconds at the dwell position and then retract. The system acquired data at 1 MHz sampling frequency and averaged it over 10 samples to minimise variance due to electrical and thermal noise. The 215 cylindrical insert was rotated in a clockwise direction for a total of 180° rotation with measurements taken at every 30° increment. There was no need to measure along a full rotation due to the rectangular diode design. The diode response was normalised to 100% at 15 mm SDD. This SDD was chosen to minimise the effect of uncertainty in experimental setup and energy response of the diode associated with the softening of the 192 Ir spectra with SDD 24 . These results used to calculate the radial dose function and are compared to the values found within the AAPM TG-43 protocol 25 . This calculation was 240 performed to take into account the 1/r 2 dependence of the source.
III.C. HDR Source Tracking using magic plate
MP is a 2D array of diodes where each detector element is measuring energy deposited by the gamma photons or secondary electrons emitted by a source with no directional information. However, the radial SDD r can be estimated taking into account the diode response as a function of distance and 245 angle normalised to the activity of the source. Correlation of the measurements taken by three or more detectors can then identify the position of the source in three dimensions using a triangulation method based on estimation and iteration 26 ( Figure 6 ). This technique requires the accurate characterisation of the detector response to 192 Ir gamma spectrum in terms of relative SDD dose and angular responses. A software tool was developed in C++ to calculate the position of the HDR source in 3D using the real time response of each detector in MP acquired by the TERA system. As three non-collinear detectors are the minimum for localisation of the source, selection of more than three allows for redundancy in estimation of the x, y and z coordinates of the source, and inaccuracy reduction. The 255 MP is an 11x11 array, and every detector can be used for estimating the source position, however, only the detector with the highest response and its immediate neighbours (2x2 or 3x3 subset) were considered to minimise uncertainty due to lower signal from the detectors at larger distances from the source as well as minimise uncertainty with non-isotropic response of the detector and emission of the source. The origin of the detector coordinate system is set at the sensor on the bottom left of MP 260 The response of the central diode in the MP per unit source air-kerma strength was measured for 265 known activity 192 Ir source in water with centre of HDR source located 10 mm above the centre of the diode under full backscattering conditions. The MP response was normalised prior to this in a 20x20 cm 2 photon field from a 6MV LINAC at a source-to-surface distance of 100 cm in a 30x30x30 cm 3 solid water phantom. The MP was placed at a depth of 10 cm, where the photon field has a flat dose profile, verified regularly using an ion chambers as part of the LINAC's quality checks. 270
Reproducibility of all diodes before normalization was better than 1%. It is assumed that the response of the detector varies linearly with the HDR source strength. 
As the source is assumed to be closest to the detector with the highest response, 1 ( 1 , 1 , 1 ), the sum 290 of the squares is calculated using the first estimation of the source position,
, with ′ derived from the equivalence of 1 and the distance between 1 and the source coordinate estimation. The second and third iterations are performed by changing ′ by ±5 mm, and then determining which sum of the squares is lower. The method is then repeated with a change in the estimation that is half of the previous, until the change is lower than 0.04 mm. The method is then 295 repeated with changes in the estimation of ′ .
This robust method essentially fits the best estimation of the source position to the detectors response.
The relative angle of each diode to the source is then calculated and corrections are then applied to the MP response based upon the angular dependence of each detector. The source position is then reestimated by the above method. 300
Validation of the source tracking method was performed using the afterloader programmed to drive the HDR source at 2.5 mm step sizes and with a dwell time of 2 seconds towards the end of the catheter. The catheter was placed within a water equivalent plastic phantom and positioned directly above the middle column of the MP detectors (x = 50 mm) with the source stepping across the y direction. The method was evaluated with MP at a SDD of 10 mm below the catheter's plane. The 305 source positions are reconstructed for each acquisition frame of the whole MP using developed routines and compared to the input of the afterloader software.
III.D. HDR source speed measurement using X-Tream System
Due to the fast acquisition sampling rate of the X-Tream system, up to 1 MHz, it is possible to measure the response of a single epitaxial diode (instantaneous dose rate) while the source is in 310 transit. The diode mounted in a kapton tail as mentioned earlier is placed at the centre of a 30x30x30 cm 3 solid water phantom, with the HDR catheter placed at 5 mm distance from the detector.
The HDR source is stepped to the first dwell position within the catheter, and is stationary for 5 seconds. It then moves to the next dwell position, with a measureable time in transit. The source remains at the second dwell position for an additional 5 seconds followed by returning to the 315 afterloader. The step size was varied from 2.5 mm to 50 mm, and the transit time and average speed were recorded. Previous evaluations of the transit velocity using direct measurements have shown a range been 5.4 to 33.1 cm/s 27, 28, 29 for the same range of step sizes.
IV. Results

IV.A. Angular Dependence 320
The directional dependence of the epitaxial diode response is shown in Figure 8 . Both data sets are normalised to 100% at 0°. The azimuth data were taken using the cylindrical insert as shown in Figure   4 . Determination of the angle for this phantom has a Type A uncertainty of 2.5°. The polar data were taken using the phantom shown in Figure 5 . As the source was driven by the HDR loader to set points with 1 mm accuracy, the estimated uncertainty is calculated to be 0.6°. Type A uncertainty in 325 response in both sets is ±0.8% (1 standard deviation), mainly due to electronic noise associated with using a single detector on a kapton tail and is obtained by repeated measurements. 
IV.B. Source-to-Detector Distance Dose Measurements
The SDD dose response of the MP to a 192 Ir source in a water equivalent plastic phantom was measured using the central element of the detector array. The source was positioned directly over the 345 sensor at the initial SDD of 6 mm from the central detector and then varied to 71 mm. The type B uncertainty associated with the alignment in the z plane was estimated as large as ±1 mm.
Measurements over 71 mm were not obtainable by the current readout system due to signal being below the measurable threshold. Deviations from expected response are seen at source-to-detector distance over 15 mm. The measured followed the TG-43 calculated radial dose function up to 30 mm within 8% and for 70 mm within 360 40%, respectively. This is due to a possible over response of the silicon detector at these SDDs due to a larger lower energy scatter contribution 31 . Although there is a differing response of MP compared to the TG-43 protocol, it does not interfere with the source position determination accuracy proposed in this work. It is also possible to see a slight drop in expected position at the start of the dwell times. This is due to the source being measured in transit between dwell positions with an acquisition speed of 100 ms. 375
IV.C. Evaluation of HDR Source Tracking
Using a faster acquisition frequency, it is possible to accurately measure the source in transit, and determine the source transit time. Figure 12 shows the temporal response of the single epitaxial diode using the X-Tream acquisition system. The HDR source moves through the catheter to the first dwell position, where it is stationary for 5 seconds, then moves 15 mm to the final dwell position, and is motionless for an additional 5 seconds. The source finally retracts back into the afterloader after this time. An increase in response 390 can be seen as the second dwell position is closer to the detector. Measurements were taken over 16 seconds, at 1 MHz sampling rate; data has been averaged by a factor of 10 to improve the signal to noise ratio on the measurements and to make data handling and processing easier. Standard deviations of the average system response for one measurement in the first and second dwell positions are found to be 3.9% and 1.9%, respectively. 395 Due to the high speed of the acquisition system, there are approximately 5000 samples when measuring the HDR source in transit, as seen in Figure 13 . The source transit time was measured as 400 the time interval between the two events when the detector response is changing more than one standard deviation above the average response at the two consecutive dwell position, to when the source reaches the average value of response of the second dwell position, thus giving an average speed for a 15 mm step size. The average transit speed was evaluated as a function of step size in the range between 2.5 and 50 mm for 3 measurements per step size. Although the discrepancy of absolute value is related to the specific afterloader, this direct 420 measurement technique show similar dependence of the source velocity with the step size. The large volume of the detector and indirect estimation of the speed lead to significant errors and uncertainty especially for short dwell distances in this method. Although there is good agreement with previous results, the use of a single detector is not recommended for an accurate evaluation of the source speed as only average source speed is measured. Using the MP array, with its constant detector spacing and a sampling rate of 100 µs, instantaneous speed measurements could be performed for any positions within treatment related 430 volume, similar to the method proposed by Minamisawa et al 13 , which uses an optical fibre system and digital oscilloscope with timing resolution of 1 nanosecond.
IV.D. High Speed HDR Source Tracking using X-Tream System
V. Conclusion
The MP detectors, detector array and readout electronics, designed originally for use in IMRT and VMAT radiotherapy quality assurance, were characterised for their use in fast HDR QA. The 435 developed epitaxial diodes, which are attractive due to their radiation hardness and high stability, were characterised in terms of measured dose and angular responses using the 192 Ir HDR source.
Further development will allow for reliable measurements at larger distances, necessary for future invivo source tracking applications and in-vivo dosimetry based on known location of the source, relative to anatomy. 440
Based on the detailed characterisation of "Magic Phantom" for QA in HDR brachytherapy using 192 Ir HDR source, the selection of the distance between MP and upper and lower planes of catheters 5-10 mm away ensures the accuracy of the iterative method. The "Magic Phantom" for QA in HDR brachytherapy will verify the correctness of the plan delivery, catheter by catheter in terms of dwelling position and time, and will help to avoid accidents associated with the malfunction of the 445 afterloader. A comparison of the "Magic Phantom" and selected devices from the literature for HDR quality assurance is presented in Table 1 . -Film which can be kept for records.
-Exists in clinical setting.
-Water equivalent detectors.
-High resolution video recorded for records.
Disadvantages: -Currently not focused on dosimetric information.
-Needs expensive
Film for every test.
-Time consuming to verify full plan.
-Need for post processing of data.
-Limited to source step size >1cm.
-Expensive device.
-User needs to watch and analyse video recording.
By reconstructing the source position based on directly measuring the radiation source any incorrect 450 estimate of the source position relative to the needle tip in planning will also be immediately identified during QA of the treatment plan. It can be used for full plan QA or for a partial verification for accelerated QA for each patient plan. A developed software interface will allow for the immediate visualisation of results and analysis of acceptance parameters in terms of tolerance of actual dwelling positions and times, in comparison with the treatment plan. 455
